April 26, 1996 in Nation/World

Monopolizing Baldness?

Associated Press

Pharmacia & Upjohn Inc. asked a judge Thursday to shut out generic competitors to its non-prescription Rogaine baldness drug, saying it met federal rules that allow a monopoly for three years.

The drug maker was stunned earlier this month when the Food and Drug Administration refused to grant that privilege and began approving generic versions of the treatment, known as minoxidil.

If allowed, the generic drugs are likely to be significantly cheaper than Rogaine’s $30 per month pricetag.

© Copyright 1996 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Get stories like this in a free daily email

Please keep it civil. Don't post comments that are obscene, defamatory, threatening, off-topic, an infringement of copyright or an invasion of privacy. Read our forum standards and community guidelines.

You must be logged in to post comments. Please log in here or click the comment box below for options.

comments powered by Disqus